BLRX
BioLineRX
BLRX
BLRX
30 hedge funds and large institutions have $5.09M invested in BioLineRX in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $6.69M → $5.09M (-$1.6M)
47% less call options, than puts
Call options by funds: $54K | Put options by funds: $101K
Holders
30
Holding in Top 10
–
Calls
$54K
Puts
$101K
Top Buyers
| 1 | +$171K | |
| 2 | +$162K | |
| 3 | +$69K | |
| 4 |
Morgan Stanley
New York
|
+$40.9K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$35.7K |
Top Sellers
| 1 | -$451K | |
| 2 | -$78K | |
| 3 | -$52K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$29K |
| 5 |
FHC
First Heartland Consultants
Lake St. Louis,
Missouri
|
-$27K |